CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study
Authors
A Chan
A Gennari
+36 more
B Overmoyer
C Twelves
CH Smorenburg
Cheng-Hsu Wang
D Laessig
D Rayson
DA Berry
E Alba
E Curtit
ES Thomas
F Tas
G Batist
H Green
Hsien-Kun Chang
JA Sparano
Jen-Shi Chen
JP Jacquin
KM Rau
Kuan-Der Lee
Kun-Ming Rau
L Livi
M Fiegl
M Martin
M Vassilomanolakis
ME O’Brien
ME O’Brien
MJ Piccart-Gebhart
P Vici
P Vineis
R Sainsbury
RC Leonard
SA Hurvitz
SE Gill
SY Rha
Yen-Yang Chen
Yung-Chang Lin
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs12885-015-...
Last time updated on 01/04/2019